Utilizing high-throughput screening with the yeast display platform, Creative Biolabs offers rapid discovery of high-affinity antibodies that precisely target difficult proteins such as those embedded in membranes. We provide customized antibody discovery and enhancement solutions, including conventional scFv/Fab antibodies, single-domain antibodies (sdAbs), bispecific constructs, and anti-idiotype formats, together with engineered molecules for CAR-T cell therapy and antibody-drug conjugates (ADCs).
Leveraging yeast display, a platform that affords both precision and high-throughput capacity, we enable the construction and rigorous screening of custom sdAb libraries and screening of sdAb candidates, prioritizing high affinity and target specificity - key determinants for successful downstream applications. Whether deployed in the refinement of diagnostic assays or the exploration of novel therapeutic avenues, our sdAb discovery service provides a strategic gateway.
Harnessing the power of yeast display, we offer bespoke bispecific antibody (BsAb) discovery and evaluation. This platform enables precise dual-targeting antibody identification, crucial for immune cell engagers and tumor therapies. From generation to binding analysis, we fine-tune affinities and specificities. Our services deliver high-quality BsAbs, accelerating research and therapeutic projects with enhanced efficacy.
Yeast display enables rapid anti-idiotype antibody discovery, crucial for immune response tracking and therapeutic validation. We identify antibodies that precisely bind variable regions, facilitating targeted immunomodulation. High-affinity anti-idiotypes support diverse applications, from personalized treatments to monoclonal antibody validation. Our service addresses development challenges, ensuring accuracy and efficiency in your therapeutic research.
The intricate and difficult-to-define structures of membrane proteins including GPCRs, ion channels, and transporters have historically posed significant obstacles for traditional antibody discovery techniques. Can yeast display technology provide the solution for antibody discovery challenges? By harnessing this advanced technology, the teams at Creative Biolabs are able to engineer custom antibodies that display both remarkable specificity and affinity, meticulously crafted to target these intricate membrane protein complexes.
The yeast display-based CAR antibody discovery platform represents an efficient system that identifies high-affinity antibodies suitable for development into CAR constructs. Next-generation cancer immunotherapy development accelerates with this streamlined process which delivers essential antibody candidates for clinical translation through its inherent properties.
Yeast display technology enables scientists to discover ADCs through the identification of antibodies that bind specific targets to ensure accurate delivery. Our service simplifies the identification of high-affinity antibodies which increases the effectiveness of ADCs development. Our specialized knowledge enables faster development of superior ADCs that improve therapeutic results.
Define project goals, identify target antigens, and clarify application needs for sdAb, BsAb, anti-idiotype, anti-membrane protein, CAR, and ADC discovery.
Prepare antigen material (e.g., membrane proteins), and obtain or generate source materials (immunization samples or synthetic sequences) for the required antibody formats.
Design and construct high-diversity yeast display libraries tailored to project requirements.
Screen libraries using yeast display, validating binders for stability, specificity, and functionality, with custom strategies for applications like anti-idiotype or anti-membrane protein antibody discovery.
Evaluate antibodies for binding affinity, stability, and function (e.g., neutralization, inhibition, activation) across antibodies.
Enhance binding strength and specificity through affinity maturation to fine-tune performance.
We transform antibodies into various required formats like multi-domain antibodies and bispecific antibodies or BsAbs, ADCs, CARs, Fc fusions together with other specialized constructs.
Our expert team stands ready to help you achieve your goals through personalized solution discussions. Our team stands ready to evaluate your unique project requirements alongside delivering full information to support cooperative work toward your research objectives.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.